Skip to Main Content

Office of the Dean

Sten H. Vermund


These are extraordinary times, and the Yale School of Public Health (YSPH) is ready to meet the challenges and seize the opportunities to advance social justice and health equity for all with curriculum reform, emphasis on research on systemic racism and health, and application of discoveries to practice.

Our school’s world-renowned infectious disease epidemiologists, modelers, and disease control experts are advising local, state, national, and international governments and agencies on the COVID-19 response. The faculty’s innovation and expertise are on full display as they work to develop novel coronavirus testing assays, methods, and detection devices; equitable vaccine and health care policies, and epidemiologically guided solutions to control the pandemic.

Systemic racism is a centuries-old public health crisis. We are committed to educating and empowering current and future generations of public health professionals with an ethos of social justice and equity across all sectors. Our new U.S. Health Justice Concentration is launching this fall to complement the myriad of school-wide efforts to integrate diversity, equity, and inclusion in all that we do. This multi-disciplinary course of study allows students to analyze and address systems and processes that perpetuate health injustice in the United States, with attention to systemic racism as a key social determinant of disease.

We continue study and action to confront the unprecedented crisis in the warming and environmental degradation of our planet. YSPH was the first to offer an online certificate in Climate

Change and Health through our Yale Center on Climate Change and Health. This fall, the new Climate Change and Health Concentration is available to students of all disciplines and aims to address the shortage of public health professionals with the educational background needed to confront this existential threat.

We are at the forefront of discovery, prevention and, mitigation of disease, injury, disability, and stigma, and we hope you will share our mission toprotect and improve the health of the public.

Public health solutions are inherently interdisciplinary, and Yale University is a laboratory for innovation. A critical component of the YSPH experience is knowing the value of collaboration. Please explore our accessible partnerships across YSPH departments, with Yale’s other extraordinary schools, and within our own 545 students, 180 staff, and 144 full-time faculty. We now extend our academic reach with 12 joint-degree programs in coordination with the other graduate and professional schools at Yale, degree partnership programs with four universities overseas, and emerging distance learning and continuing education opportunities. Our coursework is enriched by our new curriculum designed for the modern public health professional driven by experiential learning.

By harnessing technology and cultivating unique partnerships, we are expanding shared resources and fostering exchanges through our centers and initiatives in innovative social entrepreneurship, global health, mathematical modeling of infectious diseases, child and maternal health, climate change and health, implementation science methods, environmental issues in child health, LGBTQ mental health and stigma, and the humanities and arts in public health, to name a few. Local, regional, and global partnerships ensure YSPH can improve the impact of public health and disease prevention. The school has revitalized its strategic foci in support of cutting-edge research, diversity and inclusion, and equitable public health practice.

Founded in 1915 as one of the original U.S. schools of public health, we have evolved into a highly collaborative, innovative, and student-oriented professional school that continues to foster a vibrant, inclusive environment. Our work is rooted in our core values of discovery, application, and service, and YSPH’s excellence is built upon the collective achievements of our diverse community. Follow us through our website and social media, and welcome to our community!

Towards a healthier and just future,

Sten H. Vermund
Dean and Anna M.R. Lauder Professor of Public Health

YSPH on the Issues

The Role of Public Health with Dean Sten Vermund



Leadership Council

group shot
Photo by Robert A. Lisak
Standing from left to right: Mark Greenwold, Jim Crystal, David Dull, Tassos Kyriakides, Harry Levitt, William Schultz, Penny Canny, Sam Srivastava. Sitting from left to right: Thomas Dubin, George Tolis, Jennifer Weis Monsky, Ann Prestipino, Mary Lawrence

The Yale School of Public Health Leadership Council is comprised of a diverse and distinguished group of alumni and friends who have demonstrated through their careers, interests, and engagement with the school and university a commitment to promote health and prevent disease. The Council advances the school’s continued development as a global leader in public health. Its members support the Dean to strategically enhance the school’s ability to provide a superb education to its students, conduct innovative and significant research, and improve health through effective and sustainable programs.

Leadership Council Members

  • Ian H. Altman, ’80 B.A. is a founding partner of Altman & Cronin Benefit Consultants, an actuarial and retirement consulting boutique in San Francisco, CA.  Altman & Cronin is known for its expertise in longevity and retiree health/income, and Mr. Altman has an extensive practice as an expert witness in these areas.  Ian serves as Governor Jerry Brown’s appointee to the California Actuarial Advisory Panel, is Past President of the Western Pension and Benefits Conference, and serves on the Endowment and Retirement/Personnel Committees of several non-profit organizations.

    Mr. Altman received his undergraduate degree from Yale College (magna cum laude) in 1980, receiving honors in both mathematics and economics.  His wife, Laura Scher, graduated from Yale College with honors in the same class.  Their daughter Alison graduated from Yale College (’12 B.A.), receiving the undergraduate Chemistry Prize.  Their son Jonathan presently attends high school.

  • Roger Barnett is the Chairman and CEO of Shaklee Corporation and the Managing Partner of Activated Holdings LLC. Founded in 1956, Shaklee is the number one natural nutrition and green cleaning products company in the U.S., with more than 1.2 million members and distributors in the U.S., Japan, Mexico, Malaysia, Canada, Taiwan, and China. In 2000, Shaklee was the first company in the world to become Climate Neutral Certified to fully offset its carbon emissions. Mr. Barnett began his career at the investment banking firm Lazard Freres & Co. He then organized an investment group to acquire control of Arcade, Inc., which he transformed into the largest sampling company in the world, expanding from a solely U.S. operation into a global business. He was also the founder and Chairman and CEO of, which continues to be one of the leading internet retailers in the cosmetics industry. In addition, Mr. Barnett is the Managing Partner of Activated Holdings LLC, an investment vehicle for a private family holding company, controlling more than $2 billion in assets. Mr. Barnett received his undergraduate degree from Yale College (Summa Cum Laude), his law degree from Yale Law School (Senior Editor, Yale Law Journal), and his MBA from Harvard Business School. Mr. Barnett has been selected as a Global Leader for Tomorrow by the World Economic Forum (Davos). He has also been selected as a Young Leader Fellow of the National Committee on U.S.-China Relations and is a member of the Young President’s Organization. Additionally, Mr. Barnett serves as a member of the Harvard School of Public Health Leadership Council, the Health Advisory Council of Columbia Presbyterian Hospital, the Yale University President's Council on International Activities, the Board of Directors of the Elie Wiesel Foundation for Humanity, the Advisory Board of 2004 Nobel Peace Laureate Wangari Maathai's The Green Belt Movement, the Board of Directors of the Metropolitan Opera Association, and the Board of Trustees of The Fine Arts Museums Foundation of San Francisco.

  • Andrew K. Bhak is Managing Director, Group Head in Healthcare Investment Banking at BMO Capital Markets, which follows three years at J.P. Morgan, where he was responsible for the healthcare services sector. He joined J.P. Morgan from Deutsche Bank, where he was Co-Head of Healthcare Services Investment Banking. Prior to that, Andrew was at Morgan Stanley, where he served in a similar capacity and helped to build its healthcare services investment banking franchise. He has served as advisor on more than $135 billion of financing and merger & acquisitions transactions, including HMA's $7.6 billion sale to Community Health Systems, HCA's $3.8 billion IPO, US Oncology's $2.1 billion sale to McKesson, and Quest Diagnostics' $2.0 billion acquisition of Ameripath, among others. Andrew also serves on the Advisory Board of the Yale Healthcare Conference.

  • Marna Borgstrom began her career at Yale-New Haven Hospital more than 30 years ago. Her varied roles have taken her from a post-graduate fellowship, to various staff and management roles, to her 1994 promotion to the position of Executive Vice President and Chief Operating Officer. In 2005, she was appointed President and CEO of both Yale-New Haven Hospital and Yale New Haven Health System.

    The Yale New Haven Health System, which has $2 billion in revenues and employs 13,000 people in Connecticut, includes Bridgeport and Greenwich Hospitals as well.

    She serves on several national boards, including VHA, Inc. in Dallas, the Council of Teaching Hospitals and Healthcare Executives Study Society. Closer to home, she serves on the Connecticut Hospital Association’s Board of Trustees and Greater New Haven Regional Leadership Council. She was previously Chair of the Connecticut Hospital Association’s Board of Trustees and served on the Boards of the Hole in the Wall Gang Camp, the United Way of Greater New Haven and the Greater New Haven Chamber of Commerce’s Board and Executive Committee.

    Marna has been the recipient of several awards recognizing her community involvement, including ADL’s Torch of Liberty Award, YMCA’s Women In Leadership Award, Junior Achievement Hall of Fame, New Haven Business Times’ 20 Noteworthy Women, Hill Health Center’s Leadership Award, Connecticut Women in Leadership Award and she is a member of the Gateway Community College Hall of Fame.Marna Borgstrom began her career at Yale-New Haven Hospital more than 30 years ago. Her varied roles have taken her from a post-graduate fellowship, to various staff and management roles, to her 1994 promotion to the position of Executive Vice President and Chief Operating Officer. In 2005, she was appointed President and CEO of both Yale-New Haven Hospital and Yale New Haven Health System. The Yale New Haven Health System, which has $2 billion in revenues and employs 13,000 people in Connecticut, includes Bridgeport and Greenwich Hospitals as well. She serves on several national boards, including VHA, Inc. in Dallas, the Council of Teaching Hospitals and Healthcare Executives Study Society.

    Marna has been the recipient of several awards recognizing her community involvement, including ADL’s Torch of Liberty Award, YMCA’s Women In Leadership Award, Junior Achievement Hall of Fame, New Haven Business Times’ 20 Noteworthy Women, Hill Health Center’s Leadership Award, Connecticut Women in Leadership Award and she is a member of the Gateway Community College Hall of Fame.

  • Dr. Canny has extensive experience as a nonprofit leader in the Greater New Haven community for many decades. Most recently, she was the senior vice president for Grantmaking and Strategy at The Community Foundation for Greater New Haven until 2014. Dr. Canny led The Community Foundation’s efforts to use community knowledge and information to mobilize giving in the community and to advance Foundation efforts to strengthen the Greater New Haven region. She was also responsible for The Community Foundation’s grantmaking programs, nonprofit technical assistance and leadership initiatives, as well as community outreach.

    Prior to coming to The Community Foundation, she worked for a decade at Connecticut Voices for Children, a research-based policy and advocacy organization, as director of research, and in the later years, as managing director and chief operating officer. Areas of research included child poverty, children and youth indicator reports, immigration as well as educational and health disparities. Before joining Connecticut Voices for Children, Dr. Canny was assistant dean for the Yale School of Public Health where she earned a Ph.D. in Chronic Disease Epidemiology. She was also a research scientist at YSPH for many years. She maintains an appointment at YSPH and serves on its Leadership Council, Stolwijk Scholarship Committee and Centennial Committee.

    After college, Dr. Canny served in the Peace Corps in Togo, West Africa as a health educator.

    Currently, Dr. Canny continues to serve as the President of the Board of Datahaven, an online comprehensive source for data about the Greater New Haven area. Datahaven's recent report is a comprehensive indicator report for the Greater New Haven area: She is also co-chair of the Community Impact Committee at United Way and on the Board of New Hytes.

  • James B. Crystal, ’86 B.A., is a Managing Director at Tricadia Capital Management, an investment firm that manages credit-focused hedge funds and related accounts.  Prior to joining Tricadia, he was a Managing Director at Rockefeller & Co., one of the largest multi-family offices.  Before joining Rockefeller in 2008, Jim was a Senior Managing Director and Portfolio Manager at Bear Stearns Asset Management, a Managing Director at Silverback Asset Management and, from 1997 to 2004, a Senior Managing Director at Bear, Stearns & Co., serving in the Investment Banking Department and the Asset-Backed Investments Group.  Prior to joining Bear Stearns, he was a Director at predecessor companies to UBS Investment Bank from 1988 to 1997.  He serves as the Treasurer of the American Friends of Herculaneum, a non-profit organization promoting education, conservation and research relating to the ancient Roman town of Herculaneum (now a World Heritage Site), which was buried and preserved by the eruption of Mount Vesuvius in 79 A.D.  Jim received his B.A. magna cum laude from Yale College in 1986 and an A.M. from Harvard University in 1988. 

  • Thomas Dubin ’19 MPH is a pharmaceutical executive and attorney. From 2001 through 2013 he was the Chief Legal Officer and a member of the core executive team that grew Alexion Pharmaceuticals from development stage to membership in the S&P 500.  At Alexion, Tom led legal, government affairs, pricing and reimbursement, corporate communications, and other functions, and he held commercial responsibility for the company’s Australasia region. Prior to Alexion, Tom served as Vice President, General Counsel and Secretary of ChiRex, Inc., an international corporation providing advanced process development services and specialty manufacturing to the pharmaceutical industry. Tom began his career as a corporate attorney with Cravath, Swaine & Moore in New York City.  He is a past Director of BioBlast Pharmaceuticals (NASD: ORPN), on the Advisory Board of Mythic Pharmaceuticals, Trustee of American Jewish World Service, and has been elected Vice Chair of Norwalk Hospital (term begins January, 2020).  He received his J.D. from New York University School of Law, where he received the American Jurisprudence Prize in securities law, and his B.A. from Amherst College, cum laude. 

  • David Dull, ’71 B.A., ’82 J.D., is a director of Ostendo Technologies, Inc. and OnRamp Wireless, Inc. and a business advisor to several other privately-held electronics, water science and bioscience companies. In 2009, he retired after 11 years as a senior executive and general counsel of Broadcom Corporation, where he was responsible for legal affairs, intellectual property strategy and development, and mergers and acquisitions. Previously, as a partner in the law firm of Irell & Manella LLP, he represented clients in the entertainment and technology industries. For five years before and after law school, Mr. Dull was a staff member of the United Nations Association of the U.S.A., a non-profit research and advocacy organization. Mr. Dull is a trustee of Sage Hill School and Sarah Lawrence College and a former member of the Yale Law School Association Executive Committee. He and his wife reside in Newport Beach, CA. They have two children. 

  • J. (Tony) Anthony Forstmann, ’61 B.A., is the Managing Director of Forstmann & Co, LLC., and Point Capital-Forstmann & Co, LLC. He joined the merchant banking firm as an original partner in 1987. He is also a special limited partner of Forstmann Little & Co., as well as co-founder of Forstmann-Leff Associates, one of the first hedge funds in the US.  Prior to his tenure at Forstmann & Co., he was the President and Chief Executive Officer for The National Registry Inc. and was a founder of several companies, including Instinet and TIMA.

    Mr. Forstmann has served as a Director of Community Health Systems, Inc., ABC Citadel Broadcasting, Home Shopping Networks. He resides in Beverly Hills, CA, with his wife.

  • Mark Greenwold, B.A. ’66, is an attorney in Washington, D.C. and Senior Consultant to the Campaign for Tobacco-Free Kids, the leading global and national advocacy organization for tobacco control.  Mr. Greenwold advises the Campaign on federal and state regulatory issues and represents a coalition of national public health groups in litigation regarding tobacco control. Mr. Greenwold also represents States and local governments in litigation against the tobacco industry.  Previously, Mr. Greenwold served as the first Chief Counsel for Tobacco for the National Association of Attorneys General, where he represented all the States in the implementation and defense of the tobacco Master Settlement Agreement of 1998.  Mr. Greenwold had previously spent 27 years in private practice in Washington specializing in complex civil litigation.  While in private practice he worked with the Washington Lawyers Committee for Civil Rights and Urban Affairs on matters ranging from asylum to disability rights.

    Mr. Greenwold graduated from Yale with a B.A. degree magna cum laude in History, the Arts and Letters in 1966 and from Harvard Law School with a J.D. degree cum laude in 1969. Mr. Greenwold served on the Board of Governors of the Association of Yale Alumni and is a past President of the Yale Club of Washington.  He is also classical pianist.  He and his wife, Betty, reside in Washington, D.C.  They have three children, Amanda, B.A. ’92, J.D. ’98, an attorney in Washington; Simon, B.S. ’95, a computer engineer in Boston; and Diana, B.A. ’05, an art museum curator in Portland, Maine. They also have five grandchildren.

  • Clarion E Johnson, ‘76 M.D., retired from ExxonMobil Corporation as its Global Medical Director. He is presently The Chair of The Joint Commission’s International and Resource Boards. He is a Board member of The Milbank Memorial Fund Board and its Executive Committee. In addition, he is a member of The Catholic Medical Mission Board and The Quality Assurance Committee of The Bon Secours Hospital System. 

    He is a member of The National Academies Global Health Board and co-chairs its public private partnership initiative. He has a HHS Secretary appointment to The NIOSH (National Institute of Occupational Safety and Health) Advisory Board and was a member of Virginia Governor's Task Force on Health Reform and co-chair, Insurance Reform Task Force.

    He is the past chair of Virginia Health Care Foundation, and the Board of City Lights Charter School in Washington DC. He served as advisor and lecturer in the Harvard Medical School’s Department of continuing education "Global Clinic Course" 2005-2008.  In 2013, he received the President’s Award from the Oil and International Petroleum Industry Environment Conservation Association (IPIECA) and Oil and Gas Producers (OGP) for contributions to health and in 2012 he was the recipient of the Society of Petroleum Engineers (SPE) Award for Health, Safety, Security, Environment and Social Responsibility. In 2011 he received a medal from the French Army’s Institute De Recherche Biomedical for "Project Tetrapole:" a public private partnership in malaria research. He is a graduate of Sarah Lawrence College, and member of its Board of Trustees, and the Yale School of Medicine. While on active duty in the U.S. Army, he also trained as a microwave researcher at Walter Reed Army Institute of Research. He is Board Certified in Internal Medicine, Cardiology and Occupational Medicine.

  • Dr. Kyriakides collaborates with clinical researchers on numerous research projects and he provides statistical consulting on numerous research protocols. He has been an abstract mentor for young researchers at the International AIDS Conferences since 2012, leads the VACSPCC internship program and is a statistical reviewer for high-impact medical journals (Lancet Infectious Diseases and the Lancet Gastroenterology & Hepatology).

    He is the Director at the Department of Veterans' Affairs Cooperative Studies Program (VACSPCC-West Haven) and has worked, as a Senior Biostatistician, on pivotal clinical trials (The OPTIMA Trial, a multi-national HIV/AIDS treatment clinical trial; a surgical clinical trial (The OVER Trial); and a PTSD clinical trial (The VIP-STAR Trial).

    Even though his primary research focus is in the area of infectious diseases with particular emphasis on HIV/AIDS and its treatment, he has an interest in the history of medicine, social determinants of health and the socio-cultural dimension of the benefits of Greek/Mediterranean nutrition. He has recently been certified as an Olive Oil Sommelier by the International Culinary Center and the Olive Oil Education Lab in NY City.

  • Mary G. Lawrence, M.D., ’98 M.P.H., is the Deputy Director of the Department of Defense/Veterans Affairs Vision Center of Excellence in Washington, DC. The center focuses on research, clinical care integration, education, information systems, and advocacy related to vision trauma, especially injuries and diseases of the eyes and visual system incurred while on Active Duty. Previously, Dr. Lawrence was a member of the faculty at University of Minnesota where she served on the Glaucoma Service and directed the Visual Rehabilitation Service. While in Minnesota, she was also the Associate Chief of Ophthalmology at the Minneapolis Veterans Affairs Medical Center. Prior to this time, Dr. Lawrence served at Harvard Medical School where she received the Residents Teacher of the Year Award and the Dean’s Commendation for her teaching. Later she was awarded a Clinical Epidemiology Fellowship at Yale University School of Medicine as a Robert Wood Johnson Clinical Scholar. She received her B.A. in Chemistry from Mount Holyoke College and her M.D. from Jefferson Medical College in Philadelphia. Dr. Lawrence lives in Washington DC, and in NYC with her husband, James A. Lawrence, ’74 B.A., Chief Executive Officer of Rothschild North America, in NY. They have three children.

  • Harry Levitt, ‘71 B.A. Harry retired in 2018 and was a partner with MullinTBG (a national executive benefits consulting firm). He has more than 40 years of experience in corporate finance, investments, financial analysis and corporate treasury activities. Before joining MullinTBG, he worked on Wall Street, where he specialized in developing and executing investment strategies for large qualified pension plans. His corporate treasury and finance work included more than 10 years as a corporate pension plan sponsor.

     He was a frequent speaker on executive benefits and compensation topics. He was an instructor at Pepperdine University teaching finance in the MBA program and has previously been a lecturer at UCLA and the University of Southern California. Harry was on the Board of the City of Hope, a leading cancer and diabetes research and treatment center in Duarte, California, where he served on the Audit and Compensation Committees. Harry graduated from Yale University with a Bachelor of Arts degree in Economics. He received a Master of Business Administration from Harvard University. He is a Registered Representative of M Holdings Securities, Inc., a Registered Broker Dealer, Member of NASD/SIPC.

  • Jennifer Weis Monsky, ’91 MA, is an Executive Editor at St. Martin's Press in NYC. During her tenure there, she has acquired and published many health-related books including most recently CLIMATE OF HOPE by Michael Bloomberg and Carl Pope, HOW CAN I GET BETTER by Dr. Richard Horowitz and DIRT IS GOOD by Drs. Jack Gilbert and Rob Knight. She is also known for her fiction bestsellers, among them THE NANNY DIARIES, SARAH'S KEY, THE HOUSE OF NIGHT and BEHIND CLOSED DOORS. Jennifer became interested in public health through her personal experiences with Lyme Disease. She joined the Columbia Lyme and Tick-borne Diseases Research Center board in 2008, and served as its chair for 3 years. She became a pioneering member of the Gray Matters program at Columbia and continues to serve on its board. This program is devoted to funding young Fellows in Psychiatry. Additionally, she is a member of the Columbia University Psychiatry Board. As various advocacy groups have worked on addressing the Lyme Disease problem, Jennifer has participated in their national fundraising and strategic activities from both leadership and board member positions. Currently, she is on the Executive Board of Project Lyme based in NYC.  She is also a member of the UJA Publishing Executive Committee. Jennifer received her BA and MA (in English) from Yale. She is married to John Monsky, Yale '81, and is the mother of 4 children.

  • Dr. Rock G. Positano is the Founder and Director of the Non-Surgical Foot and Ankle Service and Joe DiMaggio Sports Medicine Center at the Hospital for Special Surgery (HSS) and New York-Presbyterian Hospital/Weill Cornell Medical College in New York City, where he has been on staff since 1991. 

    He is internationally known for his non-surgical approach for the treatment of foot and ankle disorders and developing treatment protocols that prevent the progression of foot and ankle deformities using conservative treatment regimens such as prescription foot orthoses and physical therapy modalities. Most often these non-surgical regimens prevent the need for surgical intervention in the active patient.

    In addition, Dr. Positano's Center at Hospital for Special Surgery in New York City also focuses on the effect that abnormal foot function has on the development of knee, hip and lower back disorders in the active and athletic population.

    Dr. Positano was featured on the front page of the New York Times in an article concerning the dangers of cosmetic foot surgery. He has authored and edited numerous peer reviewed articles and has served as the editor of 11 orthopedic/medical/podiatric textbooks ranging from non- surgical foot and ankle orthopedics, heel disorders, sports medicine, foot and ankle disorder prevention and systemic disease manifestations in the foot, ankle and lower extremity.

  • Ann Prestipino, ’80 MPH is a Senior Vice President at Massachusetts General Hospital and Massachusetts General Physician Organization as well as a Teaching Associate at Harvard Medical School.  Ann is the chair of the board of directors at Boston Medflight, a non-profit that provides critical air and ground transportation as well as a former Trustee at Martha’s Vineyard Hospital. Ann has worked at Mass General for over 30 years holding several positions of increasing responsibility.  She currently oversees many clinical/academic  departments and centers, strategic planning and plays a leadership role assisting in the development of the  Partners Healthcare System. Ann earned her BA  in 1978 from Brown University before going on to receive her MPH from the Yale School of Public  Health.

  • Laura Scher, ’80 BA, is co-founder, chairperson and former chief executive officer of Credo Mobile/Working Assets, a wireless, long distance and credit card company dedicated to building a world that is more just, humane and environmentally sustainable. 

    Laura co-founded Working Assets in 1985 on the belief that building a business and building a better world are not mutually exclusive.  Working Assets supports positive social change by donating a percentage of its revenue (from top-line sales, not bottom-line profits) to progressive nonprofit groups working for peace, human rights, equality, education, and the environment. The company also makes activism easy. Through Credo Action, members have generated millions of letters and phone calls on issues impacting the world including the environment, human rights, civil rights and international peace and freedom.

    Under Laura’s leadership, the company has donated over $75 million to progressive nonprofit groups such as Doctors without Borders, Mercy Corps, Planned Parenthood, Human Rights Watch and Rainforest Action Network. As CEO, Laura helped Working Assets grow to more than $100 million in annual revenue.  Additionally, Working Assets has appeared on Inc. Magazine’s list of fastest growing, privately held companies for five years in a row and is one of the largest private companies in San Francisco.

    Working Assets and Laura have been featured in national media, including People MagazineRosie O’Donnell ShowFortune Small BusinessNew York Times, USA Today and NBC’s Today show. The San Francisco League of Women Voters honored Laura as one of four women who could be President of the United States. In 2009 she was named one of the most inspiring women of the year by Self Magazine.

    Laura is a guest lecturer at Stanford University where she teaches social entrepreneurship to undergraduates. Laura serves on the board of’s Foundation and eScrip. She has contributed to The Business of Changing the World edited by Marc Benioff and to a children’s book titled 33 More Things Every Girl Should Know.  She has written articles for several publications on corporate social responsibility.

    Laura received a Bachelor of Arts degree in economics from Yale in 1980.  She studied international economics at the Institute for International Studies in Geneva. Laura earned an MBA from Harvard Business School and was named a Baker Scholar.

  • William B. Schultz, ‘70 BA , is a partner in the Washington, D.C. law firm Zuckerman Spaeder, where he focuses on complex regulatory litigation and provides strategic advice to companies and public interest organizations. He has worked for many years on reducing the use of tobacco products and controlling prescription drug prices. He also represents small biotechnology and generic drug companies, and individual scientists. Between 2011 and 2016, he was General Counsel of the Department of Health and Human Services. He is a member of the Committee on Science, Law and Technology, National Academy of Sciences, and for 10 years he taught at Georgetown University Law Center. He also is on the Board of the Center for Science in the Public Interest, the Board of the National Health Law Program and the Board of Trustees of Partners in Health. He was Deputy Assistant Attorney General, Civil Division, U.S. Department of Justice (1999-2000), Deputy Commissioner for Policy, Food and Drug Administration (1994-1999), and Counsel to the Subcommittee on Health and the Environment (Rep. Henry A. Waxman, chairman), Committee on Energy and Commerce, U.S. House of Representatives (1989-1994). From 1976 to 1989, Bill worked as a public interest lawyer at Public Citizen Litigation Group. He began his legal career clerking for Judge William B. Bryant, U.S. District Court, D.C. Bill received his undergraduate degree from Yale College and his law degree from the University of Virginia School of Law.

  • Sam K. Srivastava is Chief Operating Officer for Bright Health, a consumer-focused health insurance and technology company.  Prior to joining Bright Health, Sam was Chief Executive Officer of Magellan Healthcare where he focused on improving health and affordability through advanced analytics and clinical solutions. He led the strategy development, operations, product development and management, and profitability and growth of Magellan Healthcare, while positioning Magellan as a leader in the behavioral health, Medicaid and specialty healthcare markets. Srivastava also provided leadership over enterprise strategy, communication and government affairs. 

    Previously, Srivastava worked at Cigna where he was president of the national and senior business segments. He had executive management responsibility for the strategic planning, business operations, growth and financial performance for these segments, which serve approximately 18 million individuals. He was instrumental in the acquisition of HealthSpring and the pharmacy benefit management partnership with CatamaranRx. 

    Srivastava has held executive leadership positions in the commercial, senior, low-income and disabled population segments at UnitedHealth Group and HealthNet and served as a management consultant in the United States and internationally, primarily focusing on the areas of developing and improving integrated health care delivery systems for providers, insurers and governments. 

    Srivastava graduated from Kent State University with a bachelor’s degree in medical science and humanities and completed graduate work at Yale University in healthcare management. He also sits on a number of advisory boards, including Oliver Wyman, Yale School of Public Health and Yale Healthcare Conference. He is married to Dr. Lisbet Lundsberg, a member of the faculty at the Yale School of Medicine, and resides in Wilton, Conn. with their four daughters.